Silver nanoparticles in mouthwashes against infection caused by SARS-CoV-2: a scoping review

Autores

DOI:

https://doi.org/10.4322/bds.2023.e3721

Resumo

The Silver nanoparticle (AgNPs) have received attention for their antiviral potential against SARS-CoV-2. The objective is to conduct a scope review and map the scientific evidence on the use of AgNPs in mouthwashes as an adjunct in decreasing the viral load in the oral cavity of patients with SARS-CoV-2. A search was performed in the PubMed, Medline, Scielo databases, and a manual search in the reference lists, following the standards of the Joanna Briggs Institute for Scoping Review without restriction of year, language or sample size. Thus, 14 articles were included, where they researched the use of AgNPs with antiviral effect against SARS-CoV-2, mouthwashes for SARS-CoV-2 and AgNPs as mouthwashes. We can suggest that AgNPs are likely antiviral therapies for SARS-CoV-2 and its use in mouthwashes associated with other therapies are promising strands for decreasing viral load and infection by the virus.

KEYWORDS

Nanoparticles; Silver; Mouthwashes; COVID-19; SARS-CoV-2.

Downloads

Não há dados estatísticos.

Publicado

2023-06-21

Como Citar

1.
Molena KF, Martins CROG, Oliveira CAF de, Feres MFN, Queiroz AM de. Silver nanoparticles in mouthwashes against infection caused by SARS-CoV-2: a scoping review. BDS [Internet]. 21º de junho de 2023 [citado 7º de outubro de 2025];26(2). Disponível em: https://bds.ict.unesp.br/index.php/cob/article/view/3721

Edição

Seção

Artigos de Revisão de Literatura

Plaudit

Artigos mais lidos pelo mesmo(s) autor(es)